Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.
D000914:Antibodies, Viral / Q000032:analysis*; D001315:Australia; D002908:Chronic Disease; D004314:Down Syndrome / Q000150:complications* / Q000276:immunology; D005260:Female; D006509:Hepatitis B / Q000209:etiology* / Q000276:immunology; D006510:Hepatitis B Antibodies / Q000032:analysis*; D006511:Hepatitis B Antigens / Q000032:analysis*; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D007326:Institutionalization; D008137:Longitudinal Studies; D008297:Male
D000914:Antibodies, Viral; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D006514:Hepatitis B Surface Antigens